Sales revenues for January 2013

The Board of Directors of Sopharma AD (the “Company”) notifies that for January 2013 Sopharma AD realized decrease of sales revenues of 14% compared to the same period of 2012, including 3% increase of domestic sales and 19% decrease of export sales.